- Home
- HUIZ vs MURA Comparison
HUIZ vs MURA Comparison
Compare HUIZ & MURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUIZ
- MURA
- Stock Information
- Founded
- HUIZ 2006
- MURA 2013
- Country
- HUIZ China
- MURA Ireland
- Employees
- HUIZ N/A
- MURA N/A
- Industry
- HUIZ Specialty Insurers
- MURA
- Sector
- HUIZ Finance
- MURA
- Exchange
- HUIZ Nasdaq
- MURA Nasdaq
- Market Cap
- HUIZ 32.8M
- MURA 36.0M
- IPO Year
- HUIZ 2020
- MURA N/A
- Fundamental
- Price
- HUIZ $4.10
- MURA $2.08
- Analyst Decision
- HUIZ Hold
- MURA Buy
- Analyst Count
- HUIZ 1
- MURA 2
- Target Price
- HUIZ $2.30
- MURA $6.00
- AVG Volume (30 Days)
- HUIZ 670.4K
- MURA 147.9K
- Earning Date
- HUIZ 09-12-2025
- MURA 11-12-2025
- Dividend Yield
- HUIZ N/A
- MURA N/A
- EPS Growth
- HUIZ N/A
- MURA N/A
- EPS
- HUIZ 0.25
- MURA N/A
- Revenue
- HUIZ $186,519,166.00
- MURA N/A
- Revenue This Year
- HUIZ $11.94
- MURA N/A
- Revenue Next Year
- HUIZ $8.15
- MURA N/A
- P/E Ratio
- HUIZ $14.42
- MURA N/A
- Revenue Growth
- HUIZ 19.12
- MURA N/A
- 52 Week Low
- HUIZ $1.50
- MURA $0.95
- 52 Week High
- HUIZ $10.58
- MURA $4.74
- Technical
- Relative Strength Index (RSI)
- HUIZ 65.74
- MURA 51.35
- Support Level
- HUIZ $3.60
- MURA $2.06
- Resistance Level
- HUIZ $3.96
- MURA $2.12
- Average True Range (ATR)
- HUIZ 0.31
- MURA 0.02
- MACD
- HUIZ 0.01
- MURA -0.00
- Stochastic Oscillator
- HUIZ 97.14
- MURA 33.50
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.